The below is a republication of a story that featured DCRI’s Kanecia Zimmerman, MD, MPH, which appeared in Duke University School of Medicine’s digital publication, Magnify.
Have you ever wondered how physicians determine the amount of medication that is safe and most effective for a child? Duke physician-scientist and critical care pediatrician Kanecia Zimmerman’s research has focused on that exact quandary— appropriate and correct doses of medications for children. She is no stranger to seeking answers to new and challenging questions to help the youngest members of society.
This year, as communities grappled with how to get children and teenagers back to school safely during the COVID-19 pandemic, Zimmerman, MD, MPHS, an associate professor of pediatrics in the School of Medicine, was confident that she and her colleagues at Duke could help. She saw questions that needed to be answered, and she went to work.
Zimmerman teamed up with Duke physician-scientist and pediatrician Daniel Benjamin, MD, PhD, MPH, to create the ABC Science Collaborative—a consortium of scientists and experts that partners with school leaders, local health departments, and other stakeholders across the state to help interpret COVID-19 data to support schools in making data-supported decisions about school policies that would allow staff, teachers, and students to return to in-class learning.
Read the rest at the Duke University School of Medicine’s digital publication, Magnify.